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ABSTRACT
The effect of pharmaceuticals, including hormone-based contraceptives, on gut microbiota is both unclear and understudied. Our goal is to evaluate the bidirectional
interactions between these drugs and gut microbiota. Specifically, we hypothesize
that hormones influence the structure and function of gut microbial communities.
Secondly, we predict that microbial community members can metabolize the contraceptive hormones administered in the most common prescriptions. Many progestins used in hormonal contraceptives are prodrugs that have to be metabolically activated by hepatic cytochromes P450s for activation. Along with the interactions of
all the hormones and the gut microbiome, we aim to determine the capacity of gut
microbiota to activate these prodrugs and whether the gut metagenome might
encode microbial pathways that provide an alternative source of prodrug activation,
something that is unknown at this point. In this study we use an in vitro culture
system exposing gut microbiota to the most common hormones used in hormonal
contraceptives. 16S rRNA gene amplification and sequencing will be used to determine the taxonomic effects of the hormones on the microbial communities. Functional assessment will be executed using metagenome prediction. Our preliminary
data show changes in taxon abundances and diversity in the presence of hormones.
Future work we will include chemical analysis of the hormone prodrugs and active
metabolites from microbial communities exposed to only the prodrug.
This in-process project will provide information to the research community on the
role of gut bacterial communities in women relying on orally delivered hormones
for contraceptive or health purposes. It will also shed light on the potential that these
bacterial communities might be influencing the metabolism of progestin prodrugs,
something not currently known.
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WHICH HORMONES HAVE BEEN TESTED?
Ethinyl Estradiol

Drospirenone

Levonorgestrel

Norgestimate*

EXPERIMENTAL WORKFLOW
The only significant changes found in alpha
diversity plots were due
to passage of time,
Acetomitophen
NAPQI
N-acetyl-p-benzoquinone
but not as a function
of hormoneimine
exposure.
However, in beta diversity plots a shift can
be observed away from the control replicates, indicating the presence of hormone
has an effect. Beta diversity plots for all
hormones at 24 and 72 hours are shown
below, and a plot for levonorgestrel at 72
hours is shown above.

(1) Contamination control
(2) Negative control
(3) Solvent control
(4) 0.1x concentration
(5) 1x concentration
(6) 10x concentration
Microbial community is thawed and split
across multiple culture tubes in Coy chamber

PRELIMINARY RESULTS
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RESEARCH GOAL
Determine whether contraceptive hormones have an
effect on bacterial community structure in the gut.
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FUTURE WORK
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Sample preparation carried out in
Coy anaerobic chamber, on ice

Cryoprotectant added, aliquotted, and frozen

The taxon abundance plots show an initial decrease
in Proteobacteria at the 24 hour timepoint, followed
by an increase of growth at the 72 hour timepoint.
Proteobacteria is present in the original microbial
communities used for culturing as is shown in the
figure on the left.

As a continuation of this project we will test additional hormones on microbial communities from additional donors. We will test the combinatorial effects of estrogen and progestins when dosed simulataneously. Several
presciption formulations of oral contraceptives contain iron in the form of
ferrous fumarate. Further investigation into the role of iron in combination
with contraceptive hormones will be addressed. Addtitionally, we will assess
whether prodrugs have the same effect on taxon abundance and diversity as
activated drugs and if we can chemically detect their presence.
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